44 results about "Circovirus" patented technology

The present invention discloses a recombinant porcine circovirus type 3 trimer protein, a preparation method and an application thereof. The present invention uses bioinformatics methods and resources to predict the B cell antigen epitopes and T cell antigen epitopes of the PCV3Cap protein. Taking into account the stability and immunogenicity of the antigen epitopes, a recombinant porcine circovirus type 3 trimer protein based on the PCV3Cap protein antigen epitope is designed, and its efficient soluble expression in Escherichia coli is achieved. The expressed recombinant porcine circovirus type 3 trimer protein can be mass-produced and purified by Ni-NTA affinity chromatography. The purified recombinant porcine circovirus type 3 trimer protein can assemble into a stable trimer structure. The subunit vaccine prepared using the recombinant porcine circovirus type 3 trimer protein can induce experimental pigs to produce a high level of antibodies and has a significant protective effect on the experimental pigs. The recombinant porcine circovirus type 3 trimer protein designed by the present invention provides a new idea for the development of PCV3 vaccine.

The invention discloses a recombinant antigen protein, a recombinant vector, a recombinant host cell, a virus-like particle and application thereof and a vaccine, and relates to the technical field of antigen preparation, the recombinant antigen protein comprises an icosahedral porcine circovirus capsid protein and an A104R protein loaded on the surface of the icosahedral porcine circovirus capsid protein, the A104R protein comprises a protein coded by an African swine fever virus A104R gene. The recombinant antigen protein capable of simultaneously reacting with positive serum of the African swine fever virus and positive serum of the porcine circovirus is prepared, and the vaccine prepared by mixing the recombinant antigen protein with an adjuvant can effectively stimulate a pig body to generate specific antibodies of the African swine fever virus and the porcine circovirus; therefore, reference is provided for joint defense of the two viruses. The recombinant antigen protein provided by the invention has the characteristics of stable expression, high yield and high solubility.

The present invention discloses a method for preparing a metal organic framework-based Pickering emulsion vaccine and its application, comprising the following steps: using Al(NO3)3·9H2O and 4,4'-diphenyldicarboxylic acid as raw materials, obtaining white DUT-5 powder by a solvothermal method; adding the prepared DUT-5 to ultrapure water, and mixing by simple ultrasound to obtain a Pickering emulsion; mixing the obtained Pickering emulsion with PCV2Cap protein and placing it in a shaking table overnight; ultrafiltration and centrifugation of the obtained mixed emulsion to obtain DUT-5-PE@CAP. The vaccine of the present invention can effectively deliver antibodies or proteins to specific locations and stimulate a strong immune response, providing new possibilities for the development of new vaccines, and providing a new method for the prevention and treatment of porcine circovirus type II, which is of great significance for controlling the disease.

The present application belongs to the field of molecular biology detection, and particularly relates to a composition, method and use for simultaneous detection and differentiation of swine fever virus, psittacosis chlamydia, porcine reproductive and respiratory syndrome virus and porcine circovirus type II. The composition for simultaneous detection provided by the present application can realize rapid detection of four pathogen target genes in one tube of reaction solution by using multiplex fluorescence RPA detection technology, and has the advantages of high throughput, short time and low cost. On one hand, the present application can accurately detect pathogens and analyze mixed infection of pathogens, so as to achieve the effect of precise medication, reduce the use of antibiotics, save costs, and reduce the cost and increase the benefit of enterprises, and on the other hand, compared with fluorescence PCR, the detection time is greatly shortened, and the purpose of rapid detection is achieved.

The present application relates to the technical field of veterinary biological products, and particularly provides a porcine circovirus type 3 (PCV3) Cap protein and a related product thereof. The PCV3 Cap protein is an NLS region 8-16aa truncated Cap protein. The amino acid sequence of the Cap protein is as shown in SEQ ID NO: 2. The present application further provides a PCV3 virus-like particle antigen, which is the PCV3 Cap protein. The Cap protein is expressed at a higher level. A vaccine prepared from the antigen exhibits strong immunogenicity and provides excellent protective efficacy.

The present application relates to the technical field of protein purification, and particularly relates to a porcine circovirus vaccine protein purification device, which comprises a protein purification instrument, a tray is arranged on the top of the protein purification instrument, and a connecting mechanism is arranged at the connecting position of the tray and the protein purification instrument. The tray is installed and fixed through the mutual insertion of the convex block and the pin rod, so that the tray is more convenient to take down and install and is easy to clean. The internal inclined surface of the tray achieves the effect of flow guiding, liquid is stored in the water collecting box, dripping on the experiment table is avoided, the safety of the experiment is improved, the height adjustment of the bracket is more convenient through the cooperation of the arc-shaped clamping block and the arc-shaped groove, the positioning effect is achieved through the cooperation of the spherical convex and the spherical groove, the adjustment of the installation position of the pre-packed column is more convenient, and the operation is more simple and convenient during the protein purification operation.

The invention discloses construction and application of a recombinant PRRSV (Porcine Reproductive and Respiratory Syndrome Virus) strain for expressing porcine circovirus Cap protein. The recombinant PRRSV capable of expressing the Cap protein of the porcine circovirus type 2 is successfully constructed and saved by adopting a reverse genetic manipulation technology. The modified virus is inoculated to Marc-145 cells for subculture, and the result shows that the modified virus can trigger cytopathy and stably express Cap protein. The obtained recombinant strain shows a stable passage capability in a Marc-145 cell, and has an extremely high virus load. The strain can be used as a vaccine candidate strain, provides multiple protection for PRRSV and porcine circovirus of different pedigree, and provides a brand new solution for healthy breeding of pigs.

The application provides a construction and application of a recombinant pseudorabies virus strain stably and efficiently expressing green fluorescent protein, in the research, a green fluorescent protein gene (EGFP) is inserted into different positions of a double gene deletion vaccine strain (JS-2012-△gE / gI) of a pseudorabies virus mutant strain by using a homologous recombination method. Finally, it is proved that the recombinant virus JS-2012-△gE / gI-VP1 / 2-EGFP has good genetic stability, and the EGFP gene can also be stably and efficiently expressed, and the growth rate on cells is also comparable to that of the parent virus, so that the VP1 / 2 gene is the best exogenous gene insertion site. Subsequently, the classical swine fever virus E2 gene, the parvovirus VP2 gene, the cap gene of the circovirus type 2 and the VP1 gene of the foot-and-mouth disease virus can be replaced or inserted into the EGFP expression frame in a single or combined manner to construct different types of multi-vaccines, and the multi-vaccines have extremely high research value and platform significance.

The invention discloses an mRNA vaccine composition for combined treatment of porcine circovirus and application of the mRNA vaccine composition. The combination comprises a nucleotide combination, the nucleotide combination comprises a sequence for coding the Cap protein of the porcine circovirus and a CpG adjuvant, and the sequence for coding the Cap protein of the porcine circovirus and the CpG adjuvant are respectively assembled into a porcine circovirus mRNA vaccine and a CpG adjuvant mRNA vaccine. In order to solve the problem that the existing mRNA vaccine generally depends on inherent immune stimulation of mRNA and LNP, and generally, an exogenous adjuvant is not additionally added, so that the immune response intensity or persistence is insufficient possibly, the CpG adjuvant and the PCV2 Cap mRNA-LNP vaccine are creatively combined for use; experiments show that the combination can significantly improve the neutralizing antibody level and enhance the immune response of Th1 type cells compared with mRNA independent immunization, has good safety, and can be used for preventing and / or treating PCV2 infection.

The present invention relates to a porcine circovirus type 2 antibody detection kit. The porcine circovirus type 2 antibody detection kit of the present invention comprises an antibody detection chip, wherein the antibody detection chip comprises a solid phase carrier and polypeptides represented by SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, and SEQ ID NO: 5, respectively immobilized on the solid phase carrier. The porcine circovirus type 2 antibody detection kit of the present invention can be used to distinguish pigs immunized with porcine circovirus type 2 inactivated vaccine from pigs infected with porcine circovirus type 2 wild-type virus.

The application discloses a kind of anti-swine circovirus type 3 Cap protein monoclonal antibodies, the anti-swine circovirus type 3 Cap protein monoclonal antibodies is monoclonal antibody P3, wherein the amino acid sequence of the heavy chain variable region and light chain variable region of monoclonal antibody P3 is respectively shown as SEQ ID NO.3 and SEQ ID NO.4.The application further discloses a kind of swine circovirus type 3 antibody detection kit, the reagent kit includes monoclonal antibody P3 and swine circovirus type 3 Cap protein and matched detection reagent.The monoclonal antibody P3 has the advantages of good specificity and good affinity, and can be used for the detection of swine circovirus type 3 antibody and the development of related detection products.Meanwhile, the reagent kit of the application has good specificity and sensitivity, and is suitable for wide range detection of swine circovirus type 3 antibody.

The invention discloses a porcine circovirus type 2 neutralizing antibody and a hybridoma cell strain secreting the same. The invention also discloses sequence information of heavy chain and light chain variable regions of the neutralizing antibody and fully verifies a key site for binding the neutralizing antibody with Cap protein. The porcine circovirus type 2 neutralizing antibody can specifically recognize porcine circovirus type 2 and porcine circovirus type 2 Cap protein, has high neutralizing activity on PCV2b and PCV2d, and is of great significance in guiding PCV2 vaccine design and developing therapeutic antibodies.

The invention provides a porcine circovirus type 5 Cap protein, a virus-like particle, an elisa plate, an ELISA kit and application thereof, and belongs to the technical field of animal viruses. The invention provides a porcine circovirus type 5 Cap protein with an amino acid sequence as shown in SEQ ID NO. 1. The porcine circovirus type 5 Cap protein provided by the invention has the advantages of stable structure and good antigenicity, can be specifically combined with a circovirus type 5 antibody in a serum sample, and can be self-assembled into 60 virus-like particles. The ELISA plate and the ELISA kit for detecting the porcine circovirus type 5, provided by the invention, have the advantages of strong specificity and high sensitivity, and can accurately detect whether a blood sample contains the porcine circovirus type 5 or not. The porcine circovirus type 5 virus-like particle provided by the invention has the advantages of high yield, good uniformity and strong stability, and can be subsequently prepared into a porcine circovirus type 5 subunit vaccine.

The application belongs to the technical field of biotechnology, and particularly discloses a synthetic peptide antigen of porcine circovirus type 2 Cap protein, a polyclonal antibody and application thereof. In order to solve the technical defects of low specificity and inaccurate detection of the amino acid sequence of the synthetic peptide antigen in the prior art, the application provides a synthetic peptide antigen of PCV2 Cap protein, a polyclonal antibody and application thereof. The application obtains an amino acid sequence of an antigen peptide by performing antigen peptide prediction on PCV2 Cap protein, and the applicant synthesizes the antigen peptide by using an Fmoc solid phase method, and immunizes a New Zealand white rabbit with the obtained antigen peptide to prepare a polyclonal antibody of Cap protein, the antibody can effectively react with a transiently expressed Cap protein and a Cap protein in PCV2b-infected PK15 cells, and provides a powerful tool for detection and biological function research of the PCV2 Cap protein.

This invention relates to the field of cell culture technology, specifically to a cell culture tank for producing porcine circovirus vaccine. The tank includes a main body with a feeding port at the top, a fixing box at the top, and a heat dissipation vent at the top of the fixing box. A stirring mechanism is located inside the main body. The first cone design achieves a shearing and flow-diverting effect, the arc surface guides the flow, reducing cell damage, and the spherical protrusions and through-holes further enhance the flow disturbance effect. The row of staggered spherical protrusions further improves the mixing effect. The two flow-dispersing blocks are arranged in opposite directions, achieving mixing in both forward and reverse rotation. The second cone design reduces resistance during reverse rotation without affecting mixing.

The present invention in particular relates to a method for reducing virus shedding, colonization of lymphoid tissue, and / or lymphoid depletion caused by or associated with a porcine circovirus type 2 (PCV2) infection in a pig, the method comprising administering orally to the pig an immunogenic composition comprising non-replicating PCV2 antigen. In one example, an immunogenic composition is administered via the oral route to a pig, wherein the immunogenic composition comprises a recombinantly produced and purified PCV2 ORF2 protein. This allows to simply reduce virus shedding, colonization of lymphoid tissue, and / or lymphoid depletion caused by associated with a PCV2 infection in the pigs, while simultaneously reducing the propensity for adverse reactions, eliminating the risk of injection site reactions, avoiding pain, and putting less stress on the animals.

The application discloses a bovine viral diarrhea virus chimeric virus expressing porcine circovirus type 3 capsid protein and a preparation method thereof. In the experiment, a gene sequence for encoding a porcine circovirus type 3 capsid protein and a His tag fused with the C terminal of the protein is inserted into different sites of a bovine viral diarrhea virus genome through a circular polymerase extension reaction, and the chimeric virus is prepared through virus rescue of the obtained circular DNA. The His tag sequence in the gene sequence and the bovine viral diarrhea virus genome are connected through a 2A peptide sequence, so as to realize the target of effectively releasing the antigen through the co-expression of the heterologous protein. The chimeric virus prepared by the application retains the infectivity and replication capacity of the parent virus, can stably replicate in cells and efficiently express the target antigen, and provides an efficient and flexible virus carrier platform for the research and development of a porcine circovirus type 3 vaccine.

The application belongs to the field of biological detection, and particularly relates to an isothermal amplification kit for detecting porcine circovirus type 3. The application provides an isothermal amplification detection primer group for porcine circovirus type 3 (PCV3), which comprises a pair of outer primers (LOF and LOR) and a pair of inner primers (LIF and LIR) and is designed according to the conserved sequence of the porcine circovirus type 3. The primer group has low design difficulty, and maintains similar sensitivity and specificity to other isothermal amplification reactions such as a loop-mediated isothermal amplification method, can be suitable for target sequences with higher GC content and below 200 bp, has no denaturation and annealing process, is suitable for on-site detection, and has great application potential.

The invention discloses a recombinant adenovirus carrying a porcine circovirus type 3 Cap gene as well as a construction method and application thereof. The recombinant adenovirus is obtained by homologous recombination of a replication-defective adenovirus skeleton plasmid and a recombinant adenovirus shuttle plasmid carrying a target gene, a replication-defective adenovirus skeleton plasmid is pBHGlox [delta] E1, 3Cre; the target gene comprises one or more copied PCV3 Cap genes, the sequence of the PCV3 Cap genes is obtained through codon optimization and is as shown in SEQ ID NO.1, tPA signal peptide is fused at the N end of the PCV3 Cap genes, and the sequence of the target gene is as shown in SEQ ID NO.2. The vaccine prepared from the recombinant adenovirus not only can effectively promote mice to generate strong body fluid and cellular immunity, but also can induce the mice to generate high-level SIgA, thereby helping to resist the attack of the porcine circovirus type 3, and having a wide application prospect.

The invention provides a subunit vaccine composition for swine fever, porcine pseudorabies, porcine circovirus and swine erysipelas as well as a preparation method and application of the subunit vaccine composition. The subunit vaccine composition comprises prokaryotically expressed swine erysipelas filamentous bacillus SpaA protein, viral subunit protein and pharmaceutically acceptable adjuvants. Wherein the amino acid sequence of the prokaryotically expressed swine erysipelas filamentous bacillus SpaA protein is as shown in SEQ No.1, and the viral subunit protein is selected from one or more of subunit E2 protein of hog cholera virus, gD protein of porcine pseudorabies virus, gB protein of porcine pseudorabies virus and cap protein of porcine circovirus type 2. The vaccine composition disclosed by the invention has the advantages of strong immunogenicity, good safety, no immune interference, high neutralizing antibody titer and long antibody duration; the infection of swine erysipelas filamentous bacillus can be effectively prevented and protected.

This invention discloses a porcine circovirus vaccine filling device, relating to the field of vaccine filling technology. The device includes a filling assembly comprising a base, a support frame on top of the base, the support frame being L-shaped, a servo motor at the top of the support frame, and a connecting frame fixedly mounted on the bottom telescopic end of the servo motor through the support frame. The connecting frame has several sets of mounting holes arranged sequentially, through which connecting pipes are installed. This invention, by setting up the filling assembly, can effectively buffer the filling process. The sieve plate provides effective buffering and defoaming, solving the problem of air bubbles easily generated during filling in existing devices. It avoids the problem of large differences in drug dosage due to air bubbles, ensuring the product complies with veterinary pharmacopoeia regulations. Simultaneously, it prevents oxygen in the air bubbles from accelerating the oxidative denaturation of vaccine antigen proteins, ensuring the drug's efficacy and preventing immunization failure.

The application discloses a recombinant orf virus for expressing PCV3 Cap protein, and the recombinant orf virus is obtained by the following steps: firstly, replacing the 132 gene of the orf virus with a nucleotide sequence, such as the gene sequence 1 of SEQ ID NO: 5, to obtain a recombinant virus 1; and secondly, replacing the nucleotide sequence, such as the gene sequence 1 of SEQ ID NO: 5, in the recombinant virus 1 with a nucleotide sequence, such as the gene sequence 2 of SEQ ID NO: 6, to obtain the recombinant orf virus. The application replaces the 132 gene of the ORFV virus with the optimized Cap gene of the PCV3 to prepare the recombinant orf virus. The recombinant orf virus can stably express the PCV3 Cap protein, and provides a vaccine candidate strain for preventing the PCV3 related diseases and a feasible technical platform for developing the recombinant orf virus of other viruses.

The invention relates to the technical field of biological medicines, and particularly discloses a vaccine adjuvant composition as well as a preparation method and application thereof. The vaccine immune composition provided by the invention comprises GM-CSF and cortex albiziae saponin, and has the following advantages: 1, the vaccine immune composition can significantly improve the specific antibody level and the cytokine secretion efficiency, effectively promote the activation of killer T cells, efficiently induce the response of memory T cells, and construct a stable immune defense basis; 2, the immune level of the organism can be remarkably improved after challenge, the tissue injury risk is reduced by inhibiting replication and colonization of viruses in key target organs, and meanwhile, the body weight of the organism is promoted to be quickly recovered after challenge, so that the physiological homeostasis of the organism is better maintained; thirdly, the method is wide in adaptability and can be compatible with various veterinary vaccines such as foot-and-mouth disease vaccines, porcine reproductive and respiratory syndrome vaccines, pseudorabies vaccines and porcine circovirus type 2 vaccines. The method can be applied to the fields of research, development and preparation of vaccine adjuvants or vaccines and the like.

The application provides a pig getah virus positive serum and a preparation method and application, and belongs to the technical field of animal virology. The application provides a preparation method of a pig getah virus positive serum, wherein a CDCD pig is used as a host, neutralizing antibody titer obtained through multiple immunization of high-concentration antigen is greater than or equal to 1:512; the serum does not have cytotoxicity affecting cell culture; the CDCD pig is a pig free from maternal antibody interference, which is obtained through caesarean section, isolated feeding and artificial feeding; the positive serum does not detect pig pseudorabies virus, swine fever virus, porcine circovirus type 2, pig foot-and-mouth disease virus, bovine viral diarrhea virus, porcine infectious gastroenteritis virus, porcine epidemic diarrhea virus, porcine rotavirus, porcine parvovirus, porcine Japanese encephalitis virus antibody, and has the characteristics of high titer and no cytotoxicity.

The invention pertains to a combination of a first vaccine comprising anon-replicating immunogen of porcine circovirus type 2 (PCV-2) and a non-replicating immunogen of Mycoplasma hyopneumoniae, and a second vaccine comprising a live attenuated porcine reproductive and respiratory syndrome (PRRS) virus, for use in prophylactically treating a pig against an infection with PCV-2, an infection with Mycoplasma hyopneumoniae and an infection with PRRS virus, by associated separate injection of the first vaccine and the second vaccine into a tissue of the pig at a first and a second injection site respectively, wherein the first and second injection sites are at most 5 cm apart from each other.

The invention belongs to the technical field of livestock epidemic prevention and detection, and provides a donkey circovirus recombinant protein and application thereof. The amino acid sequence of the donkey circovirus recombinant Cap protein is as shown in SEQ ID NO: 1. The donkey circovirus recombinant Cap protein can be used for preparing a reagent for detecting donkey circovirus.

The application relates to the technical field of pathogen detection, and discloses a pathogen multiplex PCR rapid detection method based on GenomeLabTM GeXP multiplex gene expression analysis technology. A primer group composed of seven pairs of specific primers, one pair of positive control primers and one pair of universal primers is used to detect pathogens. The seven pairs of specific primers are respectively used for specifically combining with target genes of porcine fever virus, porcine reproductive and respiratory syndrome virus, pseudorabies virus, porcine parvovirus, porcine circovirus type 3, necrotic fusiform bacteria and porcine epidemic diarrhea virus. The 5' end of the universal upstream primer is provided with a fluorescent label. A two-step PCR amplification program is adopted, and rapid and accurate detection of the seven important pathogens, i.e. porcine fever virus, porcine reproductive and respiratory syndrome virus, pseudorabies virus, porcine parvovirus, porcine circovirus type 3, necrotic fusiform bacteria and porcine epidemic diarrhea virus, is successfully realized in one reaction system.

The application relates to the technical field of biology, and particularly provides an antibody specifically combined with a porcine circovirus type 3 Cap protein and products and applications thereof. The porcine circovirus type 3 Cap protein provided by the application is encoded by a sequence SEQ ID No. 1 or a degenerate sequence thereof, the antibody heavy chain variable region prepared by the application is SEQ ID No. 2, the light chain variable region is SEQ ID No. 4, and the two can be combined to prepare a porcine circovirus type 3 blocking ELISA antibody detection kit, so that the PCV3 infection state can be accurately evaluated.

The invention is applicable to the technical field of veterinary biomedicine, and provides a nano-antibody specifically bound with porcine circovirus type 2 and application thereof, nucleotide sequences of the nano-antibody are respectively shown as SEQ ID NO: 1 and SEQ ID NO: 2, and amino acid sequences of the nano-antibody are respectively shown as SEQ ID NO: 3 and SEQ ID NO: 4. The nano antibody provided by the invention can be specifically combined with porcine circovirus particles, virus neutralizing activity is shown in PK15 cells, and the multivalent nano antibody obtained by using a ferritin coupling system can significantly reduce PCV2 virus particle infection and replication and proliferation capacities.

The present invention belongs to the field of bio-agriculture, and discloses a recombinant vector, a recombinant virus and its application for preparing a swine triple vaccine. The technical problem solved by the present invention is how to prepare a triple vaccine of porcine circovirus type 2, porcine reproductive and respiratory syndrome virus and classical swine fever virus. The recombinant vector for preparing a swine triple vaccine disclosed in the present invention is a vector that inserts the coding gene of the E2-Cap2 fusion protein into a recombinant vector that can rescue porcine reproductive and respiratory syndrome virus and expresses the coding gene of the E2-Cap2 fusion protein. The E2-Cap2 fusion protein is a protein whose amino acid sequence is SEQ ID No. 3. Experiments have shown that the swine triple vaccine obtained using the recombinant vector of the present invention has good immunogenicity and can be used to simultaneously prevent diseases caused by porcine circovirus type 2, porcine reproductive and respiratory syndrome virus and classical swine fever virus.